Skip to main content
NKMAX Co., Ltd. logo

NKMAX Co., Ltd. — Investor Relations & Filings

Ticker · 182400 ISIN · KR7182400002 KO Manufacturing
Open in API
Filings indexed 501 across all filing types
Latest filing 2018-12-11 Major Shareholding Noti…
Country KR South Korea
Listing KO 182400

About NKMAX Co., Ltd.

https://nkmax.com/

NKMAX Co., Ltd. is a biotechnology company focused on developing immune-based solutions centered on Natural Killer (NK) cells. The company's primary focus is the development of adoptive cell therapies to treat incurable diseases, including cancer, autoimmune disorders, and neurodegenerative conditions. Its portfolio includes anti-cancer immunotherapy treatments and other biological products. In addition to therapeutics, NKMAX develops and markets a precision diagnostic test that measures NK cell activity. The company also manufactures and supplies specialized reagents, such as high-quality recombinant proteins and antibodies, for biotechnology research, as well as a line of health functional foods designed to support the immune system.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is used to report changes in shareholdings by major shareholders (in this case, Korea Investment Value Asset Management). In the provided taxonomy, this corresponds to a 'Major Shareholding Notification' (MRQ), which covers notifications of changes in significant share ownership levels.
2018-12-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. It details changes in share ownership by a major shareholder (Korea Investment Value Asset Management) in the company ATGen. This type of filing is specifically designed to report changes in significant shareholdings (crossing thresholds or ongoing changes by major shareholders), which aligns with the 'Major Shareholding Notification' category.
2018-12-04 Korean
전환가액의조정(제7회차)
Capital/Financing Update Classification · 95% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price for convertible bonds (제7회차 전환사채). It details the change in conversion price, the number of convertible shares, and the underlying reasons (market price decline). This type of disclosure is a standard corporate action related to capital structure and financing instruments, which falls under the 'Capital/Financing Update' category.
2018-11-30 Korean
전환가액의조정(제6회차)
Capital/Financing Update Classification · 100% confidence The document is an official regulatory filing from the Korea Exchange (KRX) regarding the adjustment of the conversion price for convertible bonds (CB). It details the specific changes to the conversion price, the number of shares, and the underlying reasons (market price decline). This falls under capital structure changes and financing updates, specifically categorized as a 'Capital/Financing Update' (CAP) within the provided schema.
2018-11-30 Korean
기업설명회(IR)개최
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the scheduling and details of an upcoming Investor Relations (IR) event (기업설명회). It provides the date, location, purpose, and contact information for the event. Since it is an announcement of an event rather than the presentation slides themselves, and it fits the criteria for a regulatory announcement regarding corporate activities, it is classified as a Regulatory Filing (RNS).
2018-11-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details changes in shareholding by a major shareholder (Korea Investment Value Asset Management) in the company 'Atigen'. This type of filing is a standard disclosure for major shareholding changes, which falls under the 'Major Shareholding Notification' category.
2018-11-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.